Requirement for ErbB2/ErbB signaling in developing cartilage and bone

Melanie C. Fisher, Gail M. Clinton, Nita J. Maihle, Caroline N. Dealy

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

During endochondral ossification, the skeletal elements of vertebrate limbs form and elongate via coordinated control of chondrocyte and osteoblast differentiation and proliferation. The role of signaling by the ErbB family of receptor tyrosine kinases, which consists of ErbB1 (epidermal growth factor receptor or EGFR), ErbB2, ErbB3 and ErbB4, has been little studied during cartilage and bone development. Signaling by the ErbB network generates a diverse array of cellular responses via formation of ErbB dimers activated by distinct ligands that produce distinct signal outputs. Herstatin is a soluble ErbB2 receptor that acts in a dominant negative fashion to inhibit ErbB signaling by binding to endogenous ErbB receptors, preventing functional dimer formation. Here, we examine the effects of Herstatin on limb skeletal element development in transgenic mice, achieved via Prx1 promoter-driven expression in limb cartilage and bone. The limb skeletal elements of Prx1-Herstatin embryos are shortened, and chondrocyte maturation and osteoblast differentiation are delayed. In addition, proliferation by chondrocytes and periosteal cells of Prx1-Herstatin limb skeletal elements is markedly reduced. Our study identifies requirements for ErbB signaling in the maintenance of chondrocyte and osteoblast proliferation involved in the timely progression of chondrocyte maturation and periosteal osteoblast differentiation.

Original languageEnglish (US)
Pages (from-to)503-513
Number of pages11
JournalDevelopment Growth and Differentiation
Volume49
Issue number6
DOIs
StatePublished - Aug 1 2007

Fingerprint

Chondrocytes
Cartilage
Osteoblasts
Extremities
Bone and Bones
Bone Development
Epidermal Growth Factor Receptor
Osteogenesis
Protein-Tyrosine Kinases
Transgenic Mice
Vertebrates
Embryonic Structures
Maintenance
Ligands
herstatin
ErbB Receptors

Keywords

  • Bone
  • Cartilage
  • ErbB
  • Herstatin
  • Proliferation
  • Skeletal development

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Cite this

Requirement for ErbB2/ErbB signaling in developing cartilage and bone. / Fisher, Melanie C.; Clinton, Gail M.; Maihle, Nita J.; Dealy, Caroline N.

In: Development Growth and Differentiation, Vol. 49, No. 6, 01.08.2007, p. 503-513.

Research output: Contribution to journalArticle

Fisher, Melanie C. ; Clinton, Gail M. ; Maihle, Nita J. ; Dealy, Caroline N. / Requirement for ErbB2/ErbB signaling in developing cartilage and bone. In: Development Growth and Differentiation. 2007 ; Vol. 49, No. 6. pp. 503-513.
@article{eae1f9ecf0354e02a40b1d3947c5bffe,
title = "Requirement for ErbB2/ErbB signaling in developing cartilage and bone",
abstract = "During endochondral ossification, the skeletal elements of vertebrate limbs form and elongate via coordinated control of chondrocyte and osteoblast differentiation and proliferation. The role of signaling by the ErbB family of receptor tyrosine kinases, which consists of ErbB1 (epidermal growth factor receptor or EGFR), ErbB2, ErbB3 and ErbB4, has been little studied during cartilage and bone development. Signaling by the ErbB network generates a diverse array of cellular responses via formation of ErbB dimers activated by distinct ligands that produce distinct signal outputs. Herstatin is a soluble ErbB2 receptor that acts in a dominant negative fashion to inhibit ErbB signaling by binding to endogenous ErbB receptors, preventing functional dimer formation. Here, we examine the effects of Herstatin on limb skeletal element development in transgenic mice, achieved via Prx1 promoter-driven expression in limb cartilage and bone. The limb skeletal elements of Prx1-Herstatin embryos are shortened, and chondrocyte maturation and osteoblast differentiation are delayed. In addition, proliferation by chondrocytes and periosteal cells of Prx1-Herstatin limb skeletal elements is markedly reduced. Our study identifies requirements for ErbB signaling in the maintenance of chondrocyte and osteoblast proliferation involved in the timely progression of chondrocyte maturation and periosteal osteoblast differentiation.",
keywords = "Bone, Cartilage, ErbB, Herstatin, Proliferation, Skeletal development",
author = "Fisher, {Melanie C.} and Clinton, {Gail M.} and Maihle, {Nita J.} and Dealy, {Caroline N.}",
year = "2007",
month = "8",
day = "1",
doi = "10.1111/j.1440-169X.2007.00941.x",
language = "English (US)",
volume = "49",
pages = "503--513",
journal = "Development Growth and Differentiation",
issn = "0012-1592",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Requirement for ErbB2/ErbB signaling in developing cartilage and bone

AU - Fisher, Melanie C.

AU - Clinton, Gail M.

AU - Maihle, Nita J.

AU - Dealy, Caroline N.

PY - 2007/8/1

Y1 - 2007/8/1

N2 - During endochondral ossification, the skeletal elements of vertebrate limbs form and elongate via coordinated control of chondrocyte and osteoblast differentiation and proliferation. The role of signaling by the ErbB family of receptor tyrosine kinases, which consists of ErbB1 (epidermal growth factor receptor or EGFR), ErbB2, ErbB3 and ErbB4, has been little studied during cartilage and bone development. Signaling by the ErbB network generates a diverse array of cellular responses via formation of ErbB dimers activated by distinct ligands that produce distinct signal outputs. Herstatin is a soluble ErbB2 receptor that acts in a dominant negative fashion to inhibit ErbB signaling by binding to endogenous ErbB receptors, preventing functional dimer formation. Here, we examine the effects of Herstatin on limb skeletal element development in transgenic mice, achieved via Prx1 promoter-driven expression in limb cartilage and bone. The limb skeletal elements of Prx1-Herstatin embryos are shortened, and chondrocyte maturation and osteoblast differentiation are delayed. In addition, proliferation by chondrocytes and periosteal cells of Prx1-Herstatin limb skeletal elements is markedly reduced. Our study identifies requirements for ErbB signaling in the maintenance of chondrocyte and osteoblast proliferation involved in the timely progression of chondrocyte maturation and periosteal osteoblast differentiation.

AB - During endochondral ossification, the skeletal elements of vertebrate limbs form and elongate via coordinated control of chondrocyte and osteoblast differentiation and proliferation. The role of signaling by the ErbB family of receptor tyrosine kinases, which consists of ErbB1 (epidermal growth factor receptor or EGFR), ErbB2, ErbB3 and ErbB4, has been little studied during cartilage and bone development. Signaling by the ErbB network generates a diverse array of cellular responses via formation of ErbB dimers activated by distinct ligands that produce distinct signal outputs. Herstatin is a soluble ErbB2 receptor that acts in a dominant negative fashion to inhibit ErbB signaling by binding to endogenous ErbB receptors, preventing functional dimer formation. Here, we examine the effects of Herstatin on limb skeletal element development in transgenic mice, achieved via Prx1 promoter-driven expression in limb cartilage and bone. The limb skeletal elements of Prx1-Herstatin embryos are shortened, and chondrocyte maturation and osteoblast differentiation are delayed. In addition, proliferation by chondrocytes and periosteal cells of Prx1-Herstatin limb skeletal elements is markedly reduced. Our study identifies requirements for ErbB signaling in the maintenance of chondrocyte and osteoblast proliferation involved in the timely progression of chondrocyte maturation and periosteal osteoblast differentiation.

KW - Bone

KW - Cartilage

KW - ErbB

KW - Herstatin

KW - Proliferation

KW - Skeletal development

UR - http://www.scopus.com/inward/record.url?scp=34547465203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547465203&partnerID=8YFLogxK

U2 - 10.1111/j.1440-169X.2007.00941.x

DO - 10.1111/j.1440-169X.2007.00941.x

M3 - Article

C2 - 17555517

AN - SCOPUS:34547465203

VL - 49

SP - 503

EP - 513

JO - Development Growth and Differentiation

JF - Development Growth and Differentiation

SN - 0012-1592

IS - 6

ER -